About UBS ETF (CH) - UBS SMIM(R) ETF Anteile -CHF dis-

SMMCHA invests in stocks. The fund's major sectors are Health Technology, with 25.83% stocks, and Producer Manufacturing, with 19.98% of the basket. The assets are mostly located in the Europe region.

SMMCHA top holdings are Sandoz Group Ltd and Galderma Group AG, occupying 9.07% and 7.60% of the portfolio correspondingly.

SMMCHA last dividends amounted to 4.42 CHF. The year before, the issuer paid 0.73 CHF in dividends, which shows a 83.48% increase.

SMMCHA assets under management is ‪1.50 B‬ CHF. It's fallen 4.43% over the last month.

SMMCHA fund flows account for ‪91.96 M‬ CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

SMMCHA shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Apr 8, 2010, and its management style is Passive.

SMMCHA expense ratio is 0.27% meaning you'd have to pay 0.27% of your investment to help manage the fund.

SMMCHA follows the Switzerland SMI Mid. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

SMMCHA invests in stocks.

SMMCHA price has fallen by −3.67% over the last month, and its yearly performance shows a 6.88% increase. See more dynamics on SMMCHA price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −2.96% over the last month, have fallen by −2.96% over the last month, showed a 0.94% increase in three-month performance and has increased by 9.12% in a year.